Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Admiral William McRaven to Keynote
2024 BIO Convention
Share
Press Release  •  April 30, 2024
Retired U.S. Navy (SEAL) Four-Star Admiral and the Former Chancellor of The University of Texas System, William McRaven, to Discuss Leadership, Global Events, and the National Security Importance of Biotechnology with BIO CEO, John CrowleyWASHINGTON - (April 30, 2024) – As recent global events have demonstrated, the world has become more challenging and American leadership is needed more at home and abroad than ever before, and that includes maintaining U.S. dominance in biotechnology innovation. Retired U.S. Navy four-star admiral, Navy SEAL, University Chancellor, best-selling author and world-renowned authority of leadership, William McRaven, will keynote the 2024 BIO International Convention, Wednesday, June 5, in San Diego. Admiral McRaven will be interviewed by John Crowley, CEO of the Biotechnology Innovation Organization (BIO) about the challenge of global events today and the implications for biotechnology as a national security imperative. McRaven will also share his insights on essential elements of leadership in managing complex organizations. Over the course of his distinguished military career, McRaven gained first-hand insight into the numerous threats facing the United States. “For more than a century, the United States has been the medicine chest to the world, providing life-saving vaccines, antibiotics, and therapeutics, saving millions of lives. In the face of diverse global threats, maintaining a robust biotech industry is paramount for safeguarding both the nation and our allies,” said McRaven.“We are on the cusp of a golden age of biotechnology, and Admiral McRaven will highlight why it is a strategic imperative for the United States to bolster our biotechnology capabilities and foster innovation in order to safeguard our nation and global society,” said Crowley. “He brings unparalleled expertise and experience to the discussion on the intersection of biotechnology and national security.” Listed as one of the world’s greatest leaders…
Read More

Admiral McRaven to keynote BIO 2024
Share
Bio.News  •  April 30, 2024
BIO announced one of the keynote speakers at the 2024 BIO International Convention: Admiral William McRaven. Plus, Sen. Sanders launched a politically motivated investigation into revolutionary, cost-effective diabetes and obesity medicines—BIO explains what you need to know. (634 words, 3 minutes, 10 seconds)
Read More

Limb loss advocates highlight progress
Share
Bio.News  •  April 29, 2024
Today we highlight April’s Limb Loss and Limb Difference Awareness Month and the economic impact of sustainable aviation fuel. (538 words, 2 minutes, 41 seconds)
Read More

Member of Congress ‘flies out’ to Nanoscope Therapeutics
Share
Bio.News  •  April 26, 2024
Rep. Jake Ellzey (R-TX) yesterday “flew out” to tour BIO member company Nanoscope Therapeutics in Arlington, TX—here’s what he learned. Plus, it’s World IP Day—a chance to highlight how strong IP enables innovation to achieve the Sustainable Development Goals. (509 words, 2 minutes, 32 seconds)
Read More

How biotech can ‘expand the state of possible’
Share
Bio.News  •  April 25, 2024
Today we recap a busy day in Boston for BIO leaders yesterday—plus, BIO member developments on agriculture and AI. (518 words, 2 minutes, 35 seconds)
Read More

BIO Office Hours
Share
BIO Business Solutions
BIO Office Hours is a resource for BIO members to meet one-on-one with subject matter experts on business services. Are you preparing for an FDA inspection or submitting a federal grant application? Not sure if you qualify for the R&D tax credit? Interested in learning about the most common startup pitfalls and how to avoid them? A few times a year, BIO invites experts to discuss business critical topics followed by the opportunity for BIO members to dig deeper on the topic with the expert.
Read More

AFPs cause 'health risks'
Share
Bio.News  •  April 24, 2024
Members of Congress weigh in on AFPs, while measles surges highlight the importance of World Immunization Week, kicking off today. (631 words, 3 minutes, 9 seconds)
Read More

Resetting R&D for AI: Biotech’s Path to AI-Ready Data & AI-Enabled Scientists
Share
Webinars  •  April 24, 2024
More than $4B of deals between biopharma companies and AI specialists were announced last year. Similar to the massive quality leap from GPT-2 to GPT-4 and the record-breaking consumer adoption rates of AI tools, that same exponential progress and uptake is coming to biotech AI. 2024 may bring the first one-trillion-parameter protein language model. Companies are already using AI to program, as opposed to discover, antibodies. This level of opportunity and change brings with it urgency—— companies need to rethink from the ground up how their R&D should work to compete in a new era defined by the intersection of biology, data, and AI. In this webinar, learn how companies are updating their approach to R&D, with a focus on: AI-Ready Data: Improving generation of high-quality biomedical data to support AI model building and model tuning AI-Enabled Scientists: Integrating the right models directly into scientists’ workflows for everyday use Scalability: Making performance, speed, privacy, and cost tradeoffs for deployment of AI, and connecting the wet and dry labs
Read More
ai

Help Ensure Providers Have Access to All Approved Immunizations
Share
Human Health, Biodefense and Vaccines  •  Toolkit  •  April 24, 2024
Providers are best equipped to choose the right vaccine for their patients. Vaccines that prevent the same disease may have clinical, dosing, and/or presentation differences (e.g., fully-liquid or non-fully-liquid vaccines requiring reconstitution). Providers develop individual preferences based on their specialized knowledge and the specific healthcare needs of their patients.
Read More

The next CRISPR frontier
Share
Bio.News  •  April 23, 2024
The I am BIO Podcast explores the next frontier for CRISPR: more effective delivery. Plus, nominations are open for BIO’s George Washington Carver and Rosalind Franklin Awards. (476 words, 2 minutes, 22 seconds)  P.S. BIO’s Education Alliance Partner, UCSF, is offering a 10-week virtual master class direct from Silicon Valley, “Entrepreneurship for Life Science/Healthcare,” offered Fall 2024.  Learn more at an info session TODAY, April 23, at 2 PM ET. 
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 57
  • 58
  • 59
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO